3rd Quarter - Report

FEDERAL STREET STRATEGIES, LLC for ALKERMES, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Policies to address the treatment opioid/alcohol/drug addiction and mental health issues. S.2543, Prescription Drug Pricing Reduction Act of 2019 H.R.3, Lower Drug Costs Now Act of 2019

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; Special Assistant, U.S. Secretary of Labor, Department of Labor.
DERRON PARKS New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (116th), S. 2543 (116th)

Alcohol and Drug Abuse ALC

Policies to address the treatment of opioid/alcohol/drug addiction and mental health issues.

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; Special Assistant, U.S. Secretary of Labor, Department of Labor.
DERRON PARKS New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.